Point72 Hong Kong LTD Coherus Bio Sciences, Inc. Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $117,265 - $226,843	16,355 Added 932.97%	18,108 $174,000
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $66,475 - $150,081	-11,344 Reduced 86.62%	1,753 $13,000
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $61,577 - $92,535	5,639 Added 75.61%	13,097 $169,000
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $117,910 - $141,627	7,458 New	7,458 $119,000
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $223,383 - $313,406	-17,617 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $228,140 - $271,477	17,617 New	17,617 $244,000
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $3,249 - $4,252	-199 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $7,041 - $10,095	-432 Reduced 68.46%	199 $4,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $8,266 - $13,945	631 New	631 $14,000
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $117 - $217	-14 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$8.65 - $16.28 $934 - $1,758	-108 Reduced 88.52%	14 $0
Q3 2018 Nov 14, 2018	BUY	$14.45 - $20.25 $1,762 - $2,470	122 New	122 $2,000
Q1 2018 May 15, 2018	SELL	$9.1 - $13.7 $14,905 - $22,440	-1,638 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$8.35 - $14.4 $13,677 - $23,587	1,638	1,638 $14,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.